ライフサイエンスコーパス: latex particle

1 d using different-sized standard polystyrene-latex particles.

2 structures are controlled by the size of the latex particles.

3 ingest both fibronectin and collagen-coated latex particles.

4 as not detected in phagolysosomes containing latex particles.

5 phagocytosis but not during phagocytosis of latex particles.

6 acrylate (HPMA) to produce charge-stabilized latex particles.

7 ntaining either silica particles or nontoxic latex particles.

8 olayer coverage of the surface by individual latex particles.

9 .1 were exposed to immune complexes or sized latex particles (0.8 or 3.2 micron in diameter).

10 After 24 hrs, 4-microm-diameter fluorescent latex particles (2 x 10(8)) were infused into the pulmon

11 ted with nanosized (20 nm) carboxyl-modified latex particles (20nCL) and carboxyl-modified CdSe/ZnS q

12 to internalize LPS-coated, but not uncoated, latex particles and because MD2/TLR4-transfected human e

13 C57BL/6 mice were given injections of latex particles and prepared for intravital hepatic micr

14 perimental setup, data analysis, and data on latex particles and yeast cells are presented.

15 ococcus aureus, (b) serum- and IgG-opsonized latex particles, and (c) synthetic soluble and insoluble

16 of monodisperse, highly charged polystyrene latex particles are polymerized within lightly cross-lin

17 Spherical latex particles are uniformly deposited on glass slides

18 n by using the RNA-oligo(dT)30 hybrid on the latex particles as the template and primer, and (ii) PCR

19 solution by oligo(dT)30 covalently linked to latex particles, buffer exchange, and continuous RT and

20 abilized polystyrene latex; remarkably, such latex particles can be readily prepared by aqueous emuls

21 assay requires a flow cytometer, two sets of latex particles coated with pneumococcal polysaccharides

22 Fluorescently labeled core-shell latex particles composed mainly of the thermoresponsive

23 d (1 mum) sulfate-functionalized polystyrene latex particles (designated as 20 nSL and 1 mSL, respect

24 solution environment for a light-scattering, latex-particle-enhanced, homogeneous immunoassay of C-re

25 In this technique latex particles, GO nanosheets, olive oil, ethanol, and

26 ynamic volume from calibrations with polymer latex particles in flow-FFF are compared to calibrations

27 onocyte phagocytosis of complement-opsonized latex particles, indicating that B. pertussis infection

28 Microscopic latex particles, modified with a mixed monomolecular fil

29 The magnetic label consists of a latex particle of mean diameter 441+/-6 nm, bearing magn

30 Latex particles of 50-170-nm sizes were covalently coupl

31 ified through film-formation of soft polymer latex particles on the surface of the polymersome, hereb

32 respiratory burst nor phagocytosis of either latex particles or serum-opsonized Staphylococcus aureus

33 Exposure of cells to sized latex particles resulted in a graded, stepwise decrease

34 Using latex particles, silica particles and carbon nanotubes a

35 by measurement of NIST-certified polystyrene latex particle standards.

36 croscopy was used to prepare digital maps of latex particle trapping patterns (eight per lung).

37 s effect was more pronounced for the smaller latex particles used in this study and highlighted possi

38 In the second method, latex particles were codeposited with the silica by spin

39 Embedded 2.1 microm polystyrene latex particles were displaced 10-100 nm using a near-in

40 C-albumin, Lsr-F, or fluorescent polystyrene latex particles were electrosprayed from aqueous buffer

41 lector interface; namely, on bare Al2O3, the latex particles were rigidly attached as compared to the

42 Macromolecules (40 kDa dextran and 20 nm latex particles) were deposited into the skin using a ph

43 tudied using streptavidin-coated polystyrene latex particles with diameters between 0.944 and 0.090 m

44 onstrated for a mixture of three polystyrene latex particles with different sizes as well as for the